Guanylate cyclase and the .NO/cGMP signaling pathway

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1411, Issue 2-3, 1999, Pages 334-350

  Denninger, John W ^a   Marletta, Michael A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Carbon monoxide; Cyclic guanosine monophosphate; Guanylate cyclase; Heme; Nitric oxide

Indexed keywords

CYCLIC GMP; GUANYLATE CYCLASE; HEMOPROTEIN; ISOENZYME; NITRIC OXIDE;

AMINO ACID SEQUENCE; CONFORMATIONAL TRANSITION; DIMERIZATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME STRUCTURE; GENE EXPRESSION SYSTEM; HUMAN; MOLECULAR CLONING; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE RELAXATION; SPECIES DIFFERENCE;

ANIMALS; CATALYSIS; CELL LINE; CYCLIC GMP; ENZYME ACTIVATION; FREE RADICALS; GENE EXPRESSION; GUANYLATE CYCLASE; HUMANS; MODELS, CHEMICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032902722     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2728(99)00024-9     Document Type: Review

References (124)

1. Rall T.W., Sutherland E.W. Formation of a cyclic adenine ribonucleotide by tissue particles. J. Biol. Chem. 232:1958;1065-1076.
2. Hardman J.G., Robison G.A., Sutherland E.W. Cyclic nucleotides. Annu. Rev. Physiol. 33:1971;311-336.
3. G.A. Robison, R.W. Butcher, E.W. Sutherland, Cyclic AMP, Academic Press, New York, 1971.
4. Ashman D.F., Lipton R., Melicow M.M., Price T.D. Isolation of adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate from rat urine. Biochem. Biophys. Res. Commun. 11:1963;330-334.
5. White A.A., Aurbach G.D. Detection of guanyl cyclase in mammalian tissues. Biochim. Biophys. Acta. 191:1969;686-697.
6. Schultz G., Böhme E., Munske K. Guanyl cyclase. Determination of enzyme activity. Life Sci. 8:1969;1323-1332.
7. Goldberg N.D., Dietz S.B., O'Toole A.G. Cyclic guanosine 3′,5′-monophosphate in mammalian tissues and urine. J. Biol. Chem. 244:1969;4458-4466.
8. Ishikawa E., Ishikawa S., Davis J.W., Sutherland E.W. Determination of guanosine 3′,5′-monophosphate in tissues and of guanyl cyclase in rat intestine. J. Biol. Chem. 244:1969;6371-6376.
9. Hardman J.G., Sutherland E.W. Guanyl cyclase, an enzyme catalyzing the formation of guanosine 3′,5′-monophosphate from guanosine triphosphate. J. Biol. Chem. 244:1969;6363-6370.
10. Katsuki S., Arnold W., Mittal C., Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J. Cyclic Nucleotide Res. 3:1977;23-35.
11. Miki N., Kawabe Y., Kuriyama K. Activation of cerebral guanylate cyclase by nitric oxide. Biochem. Biophys. Res. Commun. 75:1977;851-856.
12. Arnold W.P., Mittal C.K., Katsuki S., Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sci. USA. 74:1977;3203-3207.
13. Schultz K., Schultz G. Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferens. Nature. 265:1977;750-751.
14. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
15. Moncada S., Palmer R.M., Higgs E.A. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension. 12:1988;365-372.
16. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA. 84:1987;9265-9269.
17. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
18. 3 into nitrate is enhanced by endotoxin treatment. Proc. Natl. Acad. Sci. USA. 80:1983;4518-4521.
19. Green L.C., Ruiz de Luzuriaga K., Wagner D.A., Rand W., Istfan N., Young V.R., Tannenbaum S.R. Nitrate biosynthesis in man. Proc. Natl. Acad. Sci. USA. 78:1981;7764-7768.
20. Green L.C., Tannenbaum S.R., Goldman P. Nitrate synthesis in the germfree and conventional rat. Science. 212:1981;56-58.
21. Marletta M.A., Tayeh M.A., Hevel J.M. Unraveling the biological significance of nitric oxide. Biofactors. 2:1990;219-225.
22. Marletta M.A. Nitric oxide: biosynthesis and biological significance. Trends Biochem. Sci. 14:1989;488-492.
23. Hibbs J.B. Jr., Taintor R.R., Vavrin Z., Rachlin E.M. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157:1988;87-94.
24. Marletta M.A. Mammalian synthesis of nitrite, nitrate, nitric oxide, and N-nitrosating agents. Chem. Res. Toxicol. 1:1988;249-257.
25. Hevel J.M., White K.A., Marletta M.A. Purification of the inducible murine macrophage nitric oxide synthase. Identification as a flavoprotein. J. Biol. Chem. 266:1991;22789-22791.
26. Warner T.D., Mitchell J.A., Sheng H., Murad F. Effects of cyclic GMP on smooth muscle relaxation. Adv. Pharmacol. 26:1994;171-194.
27. Buechler W.A., Ivanova K., Wolfram G., Drummer C., Heim J.M., Gerzer R. Soluble guanylyl cyclase and platelet function. Ann. NY Acad. Sci. 714:1994;151-157.
28. Jaffrey S.R., Snyder S.H. Nitric oxide: a neural messenger. Annu. Rev. Cell Dev. Biol. 11:1995;417-440.
29. Lewis R.S., Deen W.M. Kinetics of the reaction of nitric oxide with oxygen in aqueous solutions. Chem. Res. Toxicol. 7:1994;568-574.
30. Fukuto J.M. Chemistry of nitric oxide: biologically relevant aspects. Adv. Pharmacol. 34:1995;1-15.
31. Kerwin J.F. Jr., Lancaster J.R. Jr., Feldman P.L. Nitric oxide: a new paradigm for second messengers. J. Med. Chem. 38:1995;4343-4362.
32. Giulivi C. Functional implications of nitric oxide produced by mitochondria in mitochondrial metabolism. Biochem. J. 332:1998;673-679.
33. Brown G.C. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett. 369:1995;136-139.
34. Bolotina V.M., Najibi S., Palacino J.J., Pagano P.J., Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 368:1994;850-853.
35. Sekkai D., Aillet F., Israel N., Lepoivre M. Inhibition of NF-kappaB and HIV-1 long terminal repeat transcriptional activation by inducible nitric oxide synthase 2 activity. J. Biol. Chem. 273:1998;3895-3900.
36. Spiecker M., Peng H.B., Liao J.K. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha. J. Biol. Chem. 272:1997;30969-30974.
37. Lander H.M., Sehajpal P.K., Novogrodsky A. Nitric oxide signaling: a possible role for G proteins. J. Immunol. 151:1993;7182-7187.
38. Lander H.M., Ogiste J.S., Pearce S.F., Levi R., Novogrodsky A. Nitric oxide-stimulated guanine nucleotide exchange on p21ras. J. Biol. Chem. 270:1995;7017-7020.
39. Lander H.M., Hajjar D.P., Hempstead B.L., Mirza U.A., Chait B.T., Campbell S., Quilliam L.A. A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction. J. Biol. Chem. 272:1997;4323-4326.
40. Li J., Billiar T.R., Talanian R.V., Kim Y.M. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem. Biophys. Res. Commun. 240:1997;419-424.
41. Stamler J.S., Jia L., Eu J.P., McMahon T.J., Demchenko I.T., Bonaventura J., Gernert K., Piantadosi C.A. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science. 276:1997;2034-2037.
42. Xu L., Eu J.P., Meissner G., Stamler J.S. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science. 279:1998;234-237.
43. Gow A.J., Stamler J.S. Reactions between nitric oxide and haemoglobin under physiological conditions. Nature. 391:1998;169-173.
44. Ingi T., Cheng J., Ronnett G.V. Carbon monoxide: an endogenous modulator of the nitric oxide-cyclic GMP signaling system. Neuron. 16:1996;835-842.
45. Verma A., Hirsch D.J., Glatt C.E., Ronnett G.V., Snyder S.H. Carbon monoxide: a putative neural messenger. Science. 259:1993;381-384.
46. Zakhary R., Poss K.D., Jaffrey S.R., Ferris C.D., Tonegawa S., Snyder S.H. Targeted gene deletion of heme oxygenase 2 reveals neural role for carbon monoxide. Proc. Natl. Acad. Sci. USA. 94:1997;14848-14853.
47. Stone J.R., Marletta M.A. Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry. 33:1994;5636-5640.
48. S.-C. Kuo, F.Y. Lee, C.-M. Teng, United States patent No. 5,574,168, 1996.
49. Stone J.R., Marletta M.A. Synergistic activation of soluble guanylate cyclase by YC-1 and carbon monoxide: implications for the role of cleavage of the iron-histidine bond during activation by nitric oxide. Chem. Biol. 5:1998;255-261.
50. Friebe A., Schultz G., Koesling D. Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J. 15:1996;6863-6868.
51. Lohmann S.M., Vaandrager A.B., Smolenski A., Walter U., De Jonge H.R. Distinct and specific functions of cGMP-dependent protein kinases. Trends Biochem. Sci. 22:1997;307-312.
52. Degerman E., Belfrage P., Manganiello V.C. Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). J. Biol. Chem. 272:1997;6823-6826.
53. Houslay M.D., Milligan G. Tailoring cAMP-signalling responses through isoform multiplicity. Trends Biochem. Sci. 22:1997;217-224.
54. Zagotta W.N., Siegelbaum S.A. Structure and function of cyclic nucleotide-gated channels. Annu. Rev. Neurosci. 19:1996;235-263.
55. Wedel B.J., Garbers D.L. New insights on the functions of the guanylyl cyclase receptors. FEBS Lett. 410:1997;29-33.
56. Hanoune J., Pouille Y., Tzavara E., Shen T., Lipskaya L., Miyamoto N., Suzuki Y., Defer N. Adenylyl cyclases: structure, regulation and function in an enzyme superfamily. Mol. Cell. Endocrinol. 128:1997;179-194.
57. Lindner E., Dohadwalla A.N., Bhattacharya B.K. Positive inotropic and blood pressure lowering activity of a diterpene derivative isolated from Coleus forskohli: forskolin. Arzneimittelforschung. 28:1978;284-289.
58. Seamon K.B., Padgett W., Daly J.W. Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc. Natl. Acad. Sci. USA. 78:1981;3363-3367.
59. Zhang G., Liu Y., Ruoho A.E., Hurley J.H. Structure of the adenylyl cyclase catalytic core. Nature. 386:1997;247-253.
60. Tesmer J.J., Sunahara R.K., Gilman A.G., Sprang S.R. Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsα·GTPγS. Science. 278:1997;1907-1916.
61. Fulle H.J., Garbers D.L. Guanylyl cyclases: a family of receptor-linked enzymes. Cell. Biochem. Funct. 12:1994;157-165.
62. Schulz S., Wedel B.J., Matthews A., Garbers D.L. The cloning and expression of a new guanylyl cyclase orphan receptor. J. Biol. Chem. 273:1998;1032-1037.
63. Liu Y., Ruoho A.E., Rao V.D., Hurley J.H. Catalytic mechanism of the adenylyl and guanylyl cyclases: modeling and mutational analysis. Proc. Natl. Acad. Sci. USA. 94:1997;13414-13419.
64. Koesling D., Herz J., Gausepohl H., Niroomand F., Hinsch K.D., Mülsch A., Böhme E., Schultz G., Frank R. The primary structure of the 70 kDa subunit of bovine soluble guanylate cyclase. FEBS Lett. 239:1988;29-34.
65. Nakane M., Saheki S., Kuno T., Ishii K., Murad F. Molecular cloning of a cDNA coding for 70 kilodalton subunit of soluble guanylate cyclase from rat lung. Biochem. Biophys. Res. Commun. 157:1988;1139-1147.
66. Koesling D., Harteneck C., Humbert P., Bosserhoff A., Frank R., Schultz G., Böhme E. The primary structure of the larger subunit of soluble guanylyl cyclase from bovine lung. Homology between the two subunits of the enzyme. FEBS Lett. 266:1990;128-132.
67. Nakane M., Arai K., Saheki S., Kuno T., Buechler W., Murad F. Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung. J. Biol. Chem. 265:1990;16841-16845.
68. Giuili G., Scholl U., Bulle F., Guellaen G. Molecular cloning of the cDNAs coding for the two subunits of soluble guanylyl cyclase from human brain. FEBS Lett. 304:1992;83-88.
69. Chhajlani V., Frandberg P.A., Ahlner J., Axelsson K.L., Wikberg J.E. Heterogeneity in human soluble guanylate cyclase due to alternative splicing. FEBS Lett. 290:1991;157-158.
70. Giuili G., Roechel N., Scholl U., Mattei M.G., Guellaen G. Colocalization of the genes coding for the α3 and β3 subunits of soluble guanylyl cyclase to human chromosome 4 at q31.3-q33. Hum. Genet. 91:1993;257-260.
71. Yoshikawa S., Miyamoto I., Aruga J., Furuichi T., Okano H., Mikoshiba K. Isolation of a Drosophila gene encoding a head-specific guanylyl cyclase. J. Neurochem. 60:1993;1570-1573.
72. Liu W., Yoon J., Burg M., Chen L., Pak W.L. Molecular characterization of two Drosophila guanylate cyclases expressed in the nervous system. J. Biol. Chem. 270:1995;12418-12427.
73. Shah S., Hyde D.R. Two Drosophila genes that encode the α and β subunits of the brain soluble guanylyl cyclase. J. Biol. Chem. 270:1995;15368-15376.
74. Mikami T., Kusakabe T., Suzuki N. Molecular cloning of cDNAs and expression of mRNAs encoding α and β subunits of soluble guanylyl cyclase from medaka fish Oryzias latipes. Eur. J. Biochem. 253:1998;42-48.
75. Yuen P.S., Potter L.R., Garbers D.L. A new form of guanylyl cyclase is preferentially expressed in rat kidney. Biochemistry. 29:1990;10872-10878.
76. Harteneck C., Wedel B., Koesling D., Malkewitz J., Böhme E., Schultz G. Molecular cloning and expression of a new α-subunit of soluble guanylyl cyclase. Interchangeability of the α-subunits of the enzyme. FEBS Lett. 292:1991;217-222.
77. Yu F., Warburton D., Wellington S., Danziger R.S. Assignment of GUCIA2, the gene coding for the α2 subunit of soluble guanylyl cyclase, to position 11q21-q22 on human chromosome 11. Genomics. 33:1996;334-336.
78. Gupta G., Azam M., Yang L., Danziger R.S. The β2 subunit inhibits stimulation of the α1/β1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure. J. Clin. Invest. 100:1997;1488-1492.
79. 2+/calmodulin-stimulated cGMP phosphodiesterase as components of neuronal signal transduction. Adv. Second Messenger Phosphoprotein Res. 28:1993;111-119.
80. D. Koesling, P. Humbert, G. Schultz, in: S.R. Vincent (Ed.), Nitric Oxide in the Nervous System, Academic Press, San Diego, CA, 1995, pp. 43-50.
81. Harteneck C., Koesling D., Söling A., Schultz G., Böhme E. Expression of soluble guanylyl cyclase. Catalytic activity requires two enzyme subunits. FEBS Lett. 272:1990;221-223.
82. Clark A.C., Raso S.W., Sinclair J.F., Ziegler M.M., Chaffotte A.F., Baldwin T.O. Kinetic mechanism of luciferase subunit folding and assembly. Biochemistry. 36:1997;1891-1899.
83. Fedorov A.N., Baldwin T.O. Cotranslational protein folding. J. Biol. Chem. 272:1997;32715-32718.
84. Garbers D.L. Purification of soluble guanylate cyclase from rat lung. J. Biol. Chem. 254:1979;240-243.
85. Wolin M.S., Wood K.S., Ignarro L.J. Guanylate cyclase from bovine lung. A kinetic analysis of the regulation of the purified soluble enzyme by protoporphyrin IX, heme, and nitrosyl-heme. J. Biol. Chem. 257:1982;13312-13320.
86. Waldman S.A., Murad F. Cyclic GMP synthesis and function. Pharmacol. Rev. 39:1987;163-196.
87. Stone J.R., Marletta M.A. Heme stoichiometry of heterodimeric soluble guanylate cyclase. Biochemistry. 34:1995;14668-14674.
88. Mülsch A., Gerzer R. Purification of heme-containing soluble guanylyl cyclase. Methods Enzymol. 195:1991;377-383.
89. Humbert P., Niroomand F., Fischer G., Mayer B., Koesling D., Hinsch K.D., Gausepohl H., Frank R., Schultz G., Böhme E. Purification of soluble guanylyl cyclase from bovine lung by a new immunoaffinity chromatographic method. Eur. J. Biochem. 190:1990;273-278.
90. Dierks E.A., Burstyn J.N. The deactivation of soluble guanylyl cyclase by redox-active agents. Arch. Biochem. Biophys. 351:1998;1-7.
91. Dierks E.A., Hu S.Z., Vogel K.M., Yu A.E., Spiro T.G., Burstyn J.N. Demonstration of the role of scission of the proximal histidine-iron bond in the activation of soluble guanylyl cyclase through metalloporphyrin substitution studies. J. Am. Chem. Soc. 119:1997;7316-7323.
92. Tomita T., Ogura T., Tsuyama S., Imai Y., Kitagawa T. Effects of GTP on bound nitric oxide of soluble guanylate cyclase probed by resonance Raman spectroscopy. Biochemistry. 36:1997;10155-10160.
93. P.E. Brandish, W. Buechler, M.A. Marletta, Regeneration of the ferrous heme of soluble guanylate cyclase from the nitric oxide complex: acceleration by thiols and oxyhemoglobin, Biochemistry (1998) in press.
94. Wedel B., Humbert P., Harteneck C., Foerster J., Malkewitz J., Böhme E., Schultz G., Koesling D. Mutation of His-105 in the β1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase. Proc. Natl. Acad. Sci. USA. 91:1994;2592-2596.
95. Gupta G., Kim J., Yang L., Sturley S.L., Danziger R.S. Expression and purification of soluble, active heterodimeric guanylyl cyclase from baculovirus. Protein Expr. Purif. 10:1997;325-330.
96. Buechler W.A., Singh S., Aktas J., Muller S., Murad F., Gerzer R. High-level expression of biologically active soluble guanylate cyclase using the baculovirus system is strongly heme-dependent. Adv. Pharmacol. 34:1995;293-303.
97. Zhao Y., Marletta M.A. Localization of the heme binding region in soluble guanylate cyclase. Biochemistry. 36:1997;15959-15964.
98. Zhao Y., Schelvis J.P., Babcock G.T., Marletta M.A. Identification of histidine 105 in the β1 subunit of soluble guanylate cyclase as the heme proximal ligand. Biochemistry. 37:1998;4502-4509.
99. Ignarro L.J. Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling. Pharmacol. Toxicol. 67:1990;1-7.
100. 2OH. Modulation of enzyme responses by heme proteins and their nitrosyl derivatives. J. Biol. Chem. 254:1979;8213-8222.
101. Craven P.A., DeRubertis F.R. Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. Evidence for involvement of the paramagnetic nitrosyl-heme complex in enzyme activation. J. Biol. Chem. 253:1978;8433-8443.
102. Gerzer R., Böhme E., Hofmann F., Schultz G. Soluble guanylate cyclase purified from bovine lung contains heme and copper. FEBS Lett. 132:1981;71-74.
103. Ignarro L.J., Degnan J.N., Baricos W.H., Kadowitz P.J., Wolin M.S. Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochim. Biophys. Acta. 718:1982;49-59.
104. Gerzer R., Hofmann F., Schultz G. Purification of a soluble, sodium-nitroprusside-stimulated guanylate cyclase from bovine lung. Eur. J. Biochem. 116:1981;479-486.
105. Stone J.R., Marletta M.A. Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide. Biochemistry. 35:1996;1093-1099.
106. Burstyn J.N., Yu A.E., Dierks E.A., Hawkins B.K., Dawson J.H. Studies of the heme coordination and ligand binding properties of soluble guanylyl cyclase (sGC): characterization of Fe(II)sGC and Fe(II)sGC(CO) by electronic absorption and magnetic circular dichroism spectroscopies and failure of CO to activate the enzyme. Biochemistry. 34:1995;5896-5903.
107. Deinum G., Stone J.R., Babcock G.T., Marletta M.A. Binding of nitric oxide and carbon monoxide to soluble guanylate cyclase as observed with resonance Raman spectroscopy. Biochemistry. 35:1996;1540-1547.
108. Yu A.E., Hu S.Z., Spiro T.G., Burstyn J.N. Resonance Raman-spectroscopy of soluble guanylyl cyclase reveals displacement of distal and proximal heme ligands by NO. J. Am. Chem. Soc. 116:1994;4117-4118.
109. Kim S.Y., Deinum G., Gardner M.T., Marletta M.A., Babcock G.T. Distal pocket polarity in the unusual ligand binding site of soluble guanylate cyclase: implications for the control of NO binding. J. Am. Chem. Soc. 118:1996;8769-8770.
110. Doyle M.P., Hoekstra J.W. Oxidation of nitrogen oxides by bound dioxygen in hemoproteins. J. Inorg. Biochem. 14:1981;351-358.
111. E. Antonini, M. Brunori, Hemoglobin and Myoglobin in their Reactions with Ligands, vol. 21, North-Holland Publ. Co., Amsterdam, 1971.
112. Fan B., Gupta G., Danziger R.S., Friedman J.M., Rousseau D.L. Resonance Raman characterization of soluble guanylate cyclase expressed from baculovirus. Biochemistry. 37:1998;1178-1184.
113. Stone J.R., Sands R.H., Dunham W.R., Marletta M.A. Electron paramagnetic resonance spectral evidence for the formation of a pentacoordinate nitrosyl-heme complex on soluble guanylate cyclase. Biochem. Biophys. Res. Commun. 207:1995;572-577.
114. Yuen P.S., Doolittle L.K., Garbers D.L. Dominant negative mutants of nitric oxide-sensitive guanylyl cyclase. J. Biol. Chem. 269:1994;791-793.
115. Wedel B., Harteneck C., Foerster J., Friebe A., Schultz G., Koesling D. Functional domains of soluble guanylyl cyclase. J. Biol. Chem. 270:1995;24871-24875.
116. Sunahara R.K., Beuve A., Tesmer J.J.G., Sprang S.R., Garbers D.L., Gilman A.G. Exchange of substrate and inhibitor specificities between adenylyl and guanylyl cyclases. J. Biol. Chem. 273:1998;16332-16338.
117. Artymiuk P.J., Poirrette A.R., Rice D.W., Willett P. A polymerase I palm in adenylyl cyclase? Nature. 388:1997;33-34.
118. Senter P.D., Eckstein F., Mülsch A., Böhme E. The stereochemical course of the reaction catalyzed by soluble bovine lung guanylate cyclase. J. Biol. Chem. 258:1983;6741-6745.
119. Tucker C.L., Hurley J.H., Miller T.R., Hurley J.B. Two amino acid substitutions convert a guanylyl cyclase, RetGC-1, into an adenylyl cyclase. Proc. Natl. Acad. Sci. USA. 95:1998;5993-5997.
120. Wilson E.M., Chinkers M. Identification of sequences mediating guanylyl cyclase dimerization. Biochemistry. 34:1995;4696-4701.
121. Friebe A., Koesling D. Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol. Pharmacol. 53:1998;123-127.
122. Kharitonov V.G., Sharma V.S., Magde D., Koesling D. Kinetics of nitric oxide dissociation from five- and six-coordinate nitrosyl hemes and heme proteins, including soluble guanylate cyclase. Biochemistry. 36:1997;6814-6818.
123. Kharitonov V.G., Russwurm M., Magde D., Sharma V.S., Koesling D. Dissociation of nitric oxide from soluble guanylate cyclase. Biochem. Biophys. Res. Commun. 239:1997;284-286.
124. 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48:1995;184-188.